182 related articles for article (PubMed ID: 22339675)
21. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
[TBL] [Abstract][Full Text] [Related]
23. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
[TBL] [Abstract][Full Text] [Related]
24. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
25. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
26. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma.
Krüger S; Sotlar K; Kausch I; Horny HP
Oncology; 2005; 68(2-3):269-75. PubMed ID: 16015044
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
28. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
30. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade.
Gökden N; Greene GF; Bayer-Garner IB; Spencer HJ; Sanderson RD; Gökden M
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):173-7. PubMed ID: 16785785
[TBL] [Abstract][Full Text] [Related]
32. The expression of heterochromatin protein 1α/β in the kidney tumors: a microarray immunohistochemical study.
Han B; Ziober A; Lu S; Bing Z
Ann Diagn Pathol; 2013 Apr; 17(2):172-5. PubMed ID: 23142018
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
34. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
Wang CC; Mao TL; Yang WC; Jeng YM
Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
[TBL] [Abstract][Full Text] [Related]
35. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH
Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
38. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
39. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
40. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]